Antioxidant supplement trial offers hope for MS fatigue relief
NCT ID NCT04267926
Summary
This study is testing whether MitoQ, an antioxidant dietary supplement, can reduce fatigue in people with multiple sclerosis. Forty-five participants with MS and significant fatigue will take either MitoQ or a placebo pill daily for twelve weeks. Researchers will compare fatigue levels before and after treatment to see if MitoQ makes a meaningful difference.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
VA Portland Health Care System, Portland, OR
Portland, Oregon, 97207-2964, United States
Conditions
Explore the condition pages connected to this study.